Praxis Precision Medicines PRAX
NASDAQ PRAX
$256.47 -8.02 (-3.03%)
At close: Oct 21, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Praxis Precision Medicines' Liabilities and Shareholders Equity came in at $1.39 billion for Q2 2026, up 207.0% from $452.83 million a year earlier but down 4.8% from the prior quarter.

Analysis

Praxis Precision Medicines (PRAX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Praxis Precision Medicines' Liabilities and Shareholders Equity was $937.91 million, up 94.1% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 25.3% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $483.11 million in FY2024 (+449.3%), $87.95 million in FY2023 (-23.6%), $115.13 million in FY2022 (-60.7%) and $292.75 million in FY2021 (-3.4%).
  • The five-year range for quarterly Liabilities and Shareholders Equity is $87.95 million (Q4 2023) to $1.46 billion (Q1 2026).
  • Year-over-year, Liabilities and Shareholders Equity has increased for three consecutive quarters, with growth averaging 166.8% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2024 (growth of 449.3%), and the weakest in Q4 2022 (a decline of 60.7%).
  • Business Quant data shows PRAX's Liabilities and Shareholders Equity at $1.46 billion (Q1 2026), $937.91 million (Q4 2025) and $396.39 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Praxis Precision Medicines 7.47 Bn 5.06 Bn - 1.39 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Bn
Mar 31, 2026 1.46 Bn
Dec 31, 2025 937.91 Mn
Sep 30, 2025 396.39 Mn
Jun 30, 2025 452.83 Mn
Mar 31, 2025 478.74 Mn
Dec 31, 2024 483.11 Mn
Sep 30, 2024 416.26 Mn
Jun 30, 2024 441.06 Mn
Mar 31, 2024 250.41 Mn
Dec 31, 2023 87.95 Mn
Sep 30, 2023 106.73 Mn
Jun 30, 2023 133.50 Mn
Mar 31, 2023 98.38 Mn
Dec 31, 2022 115.13 Mn
Sep 30, 2022 136.90 Mn
Jun 30, 2022 180.42 Mn
Mar 31, 2022 239.50 Mn
Dec 31, 2021 292.75 Mn
Sep 30, 2021 324.41 Mn
API Access

Praxis Precision Medicines Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PRAX&period=max&api_key=YOUR_API_KEY